This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wittbrodt, E. T Articles by Aviles, V. M Search for Related Content PubMed Articles by Wittbrodt, E. T Articles by Aviles, V. M Social Bookmarking                         What's this?

Pancreatitis and fatal ARDS following high-dose cytarabine induction for acute myelogenous leukemia

Philadelphia College of Pharmacy and Science

Victor M Aviles

University of Pennsylvania Medical Center, Philadelphia, Penn

Objective. To describe a case of fatal acute respira tory distress syndrome (ARDS) and pancreatitis aris ing from high-dose cytarabine induction therapy.

Case Summary. A 50-year-old male without a history of hepatobiliary disease and with a diagnosis of acute myelogenous leukemia was treated with high-dose cytarabine therapy. Tumor lysis occurred promptly; the white cell count reached a nadir of 100/mm ³ 3 days after initiation of therapy. Severe mid-epigastric pain, fever, hypotension, and increased lipase and amylase occurred on the 6th day of cytara bine therapy. Cytarabine was discontinued 6 days after initiation. Serum amylase and lipase were persis tently elevated; respiratory failure due to ARDS ensued, and the patient expired of refractory hypoxemia.

Discussion. Cytarabine-associated pancreatitis is a rare occurrence. Literature reports have described pancreatitis after high-dose cytarabine therapy for induction of remission of ALL and acute myelogenous leukemia. Pancreatitis resolved in all reported cases on discontinuation of cytarabine. In our patient, drug-induced pancreatitis likely provoked the onset of ARDS, which concluded with fatal respiratory failure. The absence of positive cultures decreased the likeli hood of sepsis-induced ARDS; the time course of cytarabine administration was temporally associated with the development of pancreatitis.

Conclusions. Acute pancreatitis is a rare but potentially fatal event associated with high-dose cy tarabine therapy.

Key Words: ARDS • cytarabine • leukemia; pancreatitis.

Journal of Oncology Pharmacy Practice, Vol. 3, No. 2, 110-114 (1997)
DOI: 10.1177/107815529700300204


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?